Clinical Trial Update: The Effect of Etelcalcetide on CKD-MBD [Phase 2]

View source ↗

Summary

Phase 2 trial assessing the effects of etelcalcetide on CKD-MBD and related conditions, completed with results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease-mineral and Bone Disorder
• Hyperparathyroidism Renal Type
• Renal Osteodystrophy
• Vascular Calcification

Drugs mentioned

• Etelcalcetide (etelcalcetide)

Snippet

Sponsor: Thomas Nickolas, MD MS | Conditions: Chronic Kidney Disease Mineral and Bone Disorder, Renal Osteodystrophy | Phase 2 | Status: COMPLETED | Results posted: 2023-09-21